Reports First Clinical Use AttraX Scaffold Biologic

NuVasive Launches AttraX Scaffold Biologic And Reports First Clinical Use

SAN DIEGO, June 12, 2018 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally…